Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lucid Diagnostics Inc (NQ: LUCD )

0.9720 -0.0280 (-2.80%)
Streaming Delayed Price Updated: 10:59 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,126
Open 0.9800
Bid (Size) 0.9690 (6)
Ask (Size) 0.9750 (2)
Prev. Close 1.000
Today's Range 0.9600 - 1.020
52wk Range 0.6301 - 1.580
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. 
Via InvestorPlace
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-30.07%
-30.07%
1 Month
+13.02%
+13.02%
3 Month
+14.76%
+14.76%
6 Month
+4.52%
+4.52%
1 Year
-26.92%
-26.92%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Via InvestorPlace
Earnings Preview: Lucid Diagnostics
Via Benzinga
Earnings Preview For Lucid Diagnostics
Via Benzinga
Where Lucid Diagnostics Stands With Analysts
Via Benzinga
Preview: Lucid Diagnostics's Earnings
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
A Glimpse of Lucid Diagnostics's Earnings Potential
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
Via InvestorPlace
Lucid Diagnostics Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of Lucid Diagnostics's Earnings
Via Benzinga
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 25, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 13, 2023
Via Benzinga
Earnings Scheduled For August 14, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why PAVmed Shares Are Falling Today
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.